Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Product/Service

ZCG-Backed Unimed Launches Telemedicine Solution to Further Enhance Technology Solutions For Maritime Medical Platform


Universal Marine Medical Supply International ("Unimed" or the "Company"), the leading global provider of pharmaceutical and medical solutions to the maritime industry, today announced the launch of comprehensive telemedicine capabilities, further strengthening the Company's technology-enabled maritime medical platform.

Accessing medical care at sea remains an ongoing challenge for the maritime industry due to crew members' prolonged periods away from accessible ports. This reality significantly impacts their physical and mental well-being as well as vessel operators' long-term crew retention. Unimed's telemedicine solution bridges this gap, providing 24/7 global access to experienced maritime doctors and nurses stationed at the Company's medical health center in Athens, Greece. These experts offer urgent care and mental health services to vessels and crew members across international waters, reaching them wherever they might be. The telemedicine solution is integrated into Unimed's proprietary medScale+© digital platform, currently utilized by over 5,500 vessels through a mobile app or web browser.

Through a subscription model ? which Unimed first introduced to the industry in 2018 ? medScale+ provides transparency by leveraging Unimed's virtual tracking of all vessels' on-board pharmaceutical products, vaccines, and medical supplies. By integrating telemedicine into medScale+, vessel operators combine a uniquely transparent digital tool to monitor and report their onboard medical capabilities with seamless access to timely and high-quality medical care, even when thousands of miles away from shore or an accessible port.

"For nearly 50 years, Unimed has been dedicated to safeguarding health at sea. Our telemedicine solution offers both customers and their crew members assurance of convenient access to medical care from anywhere in the world," said Sřren Andersen, CEO of Unimed. "As a longtime leader in the industry, we possess a profound understanding of the maritime industry and our customers' medical compliance and risk management needs. Introducing telemedicine continues our long track record of digital innovation to improve well-being at sea, and we look forward to rolling out this innovative, cost-effective solution globally to continue being the go-to medical partner for our growing client base."

Unimed's telemedicine services will operate from the Company's medical center in Athens, Greece, staffed exclusively with EU-certified doctors. This strategic location ensures 24/7 global coverage with access to medical specialists all familiar with the maritime industry's unique challenges. This proactive approach offers a service based on direct industry knowledge and critical customer needs and also aligns with Unimed's express mission to enhance life on board vessels and improve crew members' well-being, driving the industry forward in safety and welfare.

"As Unimed embraces the future of healthcare and wellness at sea, we see an unparalleled commitment to pioneering solutions that not only meet the unique challenges of maritime environments, but also elevate standards across the medical care industry worldwide," said James Zenni, Founder, President, and Chief Executive Officer of ZCG. "Unimed's vision represents the next step in health and wellness for maritime vessels, revolutionizing care and setting new standards with technology-driven approaches that ensure safer and healthier maritime environments for all."

Unimed is a portfolio company of Z Capital Partners, L.L.C., the private equity arm of Z Capital Group, L.L.C. ("ZCG") (www.zcg.com), a leading privately held merchant bank.

To learn more about medScale+, visit https://medscaleplus.com/.

About Unimed

Unimed is the industry leader in medical supply, equipment and oxygen distribution to global maritime industries, specializing in the delivery of integrated healthcare and safety supply chain logistical solutions to clients worldwide.

Unimed is a portfolio company of Z Capital Partners, L.L.C., the private equity arm of Z Capital Group, L.L.C. ("ZCG") (www.zcg.com), a leading privately held merchant bank.

For more information, please visit https://universalmarinemedical.com/.

About ZCG

ZCG is a leading, privately held merchant bank comprised of private markets asset management, business consulting services, technology development and solutions.

For almost 30 years, ZCG Principals have invested tens of billions in capital and have industry leading track records in private equity and credit.

ZCG has approximately $7B of AUM in asset management and its investors are some of the largest and most sophisticated global institutional investors including pension funds, endowments, foundations, sovereign wealth funds, central banks, and insurance companies.

ZCG has a global team comprised of over 400 professionals. For more information, please visit www.zcg.com.


These press releases may also interest you

at 19:04
X Financial (the "Company"), a leading online personal finance company in China, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission ("SEC") on April 29,...

at 19:00
CEAT Specialty hosted the Achievers Meet 2024, aimed to fortify bonds with Australian channel partners, featuring an immersive IPL match experience at Delhi's Arun Jaitley Stadium. Amidst the charged atmosphere on April 27th, attendees witnessed the...

at 18:55
Voxtur Analytics Corp. ("Voxtur" or the "Company"), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today announced its financial results for the three months and year ended December 31,...

at 18:45
Pfizer Inc. and Genmab A/S today announced the U.S. Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with...

at 18:45
Genmab A/S and Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with recurrent or...

at 18:45
Pond Technologies Holdings Inc. (the "Corporation" or "Pond")  announces the filing of the audited consolidated financial statements of the Corporation for the twelve months ended December 31, 2023 and the related management's discussion and analysis...



News published on and distributed by: